
Global Biotechnology Market Size, Trends & Growth Opportunity, By Technology (Nanobiotechnology, Tissue Engineering and Regeneration, DNA Sequencing, Cell-based Assays, Fermentation, PCR Technology, Chromatography, Others), By Application (Health, Food &
Description
Global Biotechnology Market Size, Trends & Growth Opportunity, By Technology (Nanobiotechnology, Tissue Engineering and Regeneration, DNA Sequencing, Cell-based Assays, Fermentation, PCR Technology, Chromatography, Others), By Application (Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Bioinformatics, Others) By Region (North America, Latin America, Europe, Asia Pacific, Central America East and Africa) and Forecast till 2030.
Global Biotechnology Market
Global Biotechnology Market was valued at US$ 1550 Mn in 2022, estimated to reach US$ 3880 Mn in 2030, with a CAGR of 12.15% from 2023-2027.
Biotechnology is the application of biology to the problem-solving and product-making processes. The most popular method is genetic engineering, which enables researchers to change an organism's DNA as they see fit.
Market Drivers
Government activities aiming at modernizing the regulatory environment, enhancing approval procedures and reimbursement practices, and standardizing clinical research all contribute to the market's growth. Growing adoption of personalized medicine and an uptick in orphan drug formulations are paving the way for new biotechnology applications and attracting a wave of cutting-edge startups, which will increase market revenue.
Impact of COVID-19
The COVID-19 pandemic has had a favorable effect on the biotechnology industry by spurring an increase in prospects and developments for the production of vaccines and drugs to treat the disease. For example, in 2021, more than 11 billion doses of the COVID-19 vaccine were produced worldwide, immunizing about half of the world's population in a single year. Additionally, mRNA vaccines' success and expedited approval procedures have increased vaccine-related revenues, as shown by the fact that Moderna, Pfizer/BioNTech, and Johnson & Johnson vaccines will collectively generate almost USD 31 billion in revenue in 2021.
Market Segmentation
The Global Biotechnology Market is segmented into Technology, Application, Distribution Channel and Growing System. By Technology such as Nanobiotechnology, Tissue Engineering and Regeneration, DNA Sequencing, Cell-based Assays, Fermentation, PCR Technology, Chromatography, Others. By Application such as Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Bioinformatics, Others.
Regional Analysis
Global Biotechnology Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. During the forecast period, the Biotechnology market in North America is expected to grow at the fastest CAGR. Due to a number of variables, including the existence of major competitors, strong R&D activities, and high healthcare spending, the regional market is expanding. Platforms based on genomics, proteomics, and cell biology are widely used in the area, which is hastening the uptake of life sciences technologies. Additionally, it is anticipated that the rising frequency of chronic diseases and the increasing use of personalized medicine apps for the treatment of serious illnesses will have a beneficial impact on market expansion in the area.
Key Players
Various key players are listed in this report such as Gilead Sciences, Inc, Bristol-Myers Squibb, Abbott Laboratories, Pfizer, Inc., Amgen Inc., Novo Nordisk A/S, Merck KGaA, Johnson & Johnson Services, Inc., Novartis AG
Market Taxonomy
By Technology
Global Biotechnology Market
Global Biotechnology Market was valued at US$ 1550 Mn in 2022, estimated to reach US$ 3880 Mn in 2030, with a CAGR of 12.15% from 2023-2027.
Biotechnology is the application of biology to the problem-solving and product-making processes. The most popular method is genetic engineering, which enables researchers to change an organism's DNA as they see fit.
Market Drivers
Government activities aiming at modernizing the regulatory environment, enhancing approval procedures and reimbursement practices, and standardizing clinical research all contribute to the market's growth. Growing adoption of personalized medicine and an uptick in orphan drug formulations are paving the way for new biotechnology applications and attracting a wave of cutting-edge startups, which will increase market revenue.
Impact of COVID-19
The COVID-19 pandemic has had a favorable effect on the biotechnology industry by spurring an increase in prospects and developments for the production of vaccines and drugs to treat the disease. For example, in 2021, more than 11 billion doses of the COVID-19 vaccine were produced worldwide, immunizing about half of the world's population in a single year. Additionally, mRNA vaccines' success and expedited approval procedures have increased vaccine-related revenues, as shown by the fact that Moderna, Pfizer/BioNTech, and Johnson & Johnson vaccines will collectively generate almost USD 31 billion in revenue in 2021.
Market Segmentation
The Global Biotechnology Market is segmented into Technology, Application, Distribution Channel and Growing System. By Technology such as Nanobiotechnology, Tissue Engineering and Regeneration, DNA Sequencing, Cell-based Assays, Fermentation, PCR Technology, Chromatography, Others. By Application such as Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Bioinformatics, Others.
Regional Analysis
Global Biotechnology Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. During the forecast period, the Biotechnology market in North America is expected to grow at the fastest CAGR. Due to a number of variables, including the existence of major competitors, strong R&D activities, and high healthcare spending, the regional market is expanding. Platforms based on genomics, proteomics, and cell biology are widely used in the area, which is hastening the uptake of life sciences technologies. Additionally, it is anticipated that the rising frequency of chronic diseases and the increasing use of personalized medicine apps for the treatment of serious illnesses will have a beneficial impact on market expansion in the area.
Key Players
Various key players are listed in this report such as Gilead Sciences, Inc, Bristol-Myers Squibb, Abbott Laboratories, Pfizer, Inc., Amgen Inc., Novo Nordisk A/S, Merck KGaA, Johnson & Johnson Services, Inc., Novartis AG
Market Taxonomy
By Technology
- Nanobiotechnology
- Tissue Engineering and Regeneration
- DNA Sequencing
- Cell-based Assays
- Fermentation
- PCR Technology
- Chromatography
- Others
- Health
- Food & Agriculture
- Natural Resources & Environment
- Industrial Processing
- Bioinformatics
- Others
- North America
- U.S.
- Canada
- Mexico
- Latin America
- Brazil
- Argentina
- Colombia
- Peru
- Chile
- Venezuela
- Rest of Latin America
- Europe
- Germany
- France
- UK
- Russia
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- New Zealand
- Singapore
- Malaysia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest Middle East & Africa
- What are the Key Opportunities in Global Biotechnology Market?
- What will be the growth rate from 2023 to 2030?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
Table of Contents
213 Pages
- 1 Introduction
- 1.1 Objective of the Study
- 1.2 Market definition
- 1.3 Market Scope
- 2 Research Methodology
- 2.1 Data Mining
- 2.2 Validation
- 2.3 Primary Interviews
- 2.4 List of Data Sources
- 3 Executive Summary
- 4 Global Biotechnology Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.2.4 Cumulative Impact due to recent Energy Crisis
- 4.2.5 Cumulative Impact due to nearing Economic Downturn
- 4.2.6 Post Covid-19 World Supply and Demand Conditions
- 4.2.7 Cumulative Impact of Russia-Ukraine Conflict
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Biotechnology Market, By Technology
- 5.1 Y-o-Y Growth Comparison, By Technology
- 5.2 Global Biotechnology Market Share Analysis, By Technology
- 5.3 Global Biotechnology Market Size and Forecast, By Technology
- 5.3.1 Nanobiotechnology
- 5.3.2 Tissue Engineering and Regeneration
- 5.3.3 DNA Sequencing
- 5.3.4 Cell-based Assays
- 5.3.5 Fermentation
- 5.3.6 PCR Technology
- 5.3.7 Chromatography
- 5.3.8 Others
- 6 Global Biotechnology Market, By Application
- 6.1 Y-o-Y Growth Comparison, By Application
- 6.2 Global Biotechnology Market Share Analysis, By Application
- 6.3 Global Biotechnology Market Size and Forecast, By Application
- 6.3.1 Health
- 6.3.2 Food & Agriculture
- 6.3.3 Natural Resources & Environment
- 6.3.4 Industrial Processing
- 6.3.5 Bioinformatics
- 6.3.6 Others
- 7 Global Biotechnology Market, By Region
- 7.1 Global Biotechnology Market Share Analysis, By Region
- 7.2 Global Biotechnology Market Share Analysis, By Region
- 7.3 Global Biotechnology Market Size and Forecast, By Region
- 8 North America Biotechnology Market Analysis and Forecast (2023-2030)
- 8.1 Introduction
- 8.2 North America Biotechnology Market Share Analysis, By Technology
- 8.3 North America Biotechnology Market Share Analysis, By Application
- 8.4 North America Biotechnology Market Size and Forecast, By Country
- 8.4.1 U.S
- 8.4.1.1 Market Size and Forecast, By Technology
- 8.4.1.2 Market Size and Forecast, By Application
- 8.4.2 Canada
- 8.4.2.1 Market Size and Forecast, By Technology
- 8.4.2.2 Market Size and Forecast, By Application
- 8.4.3 Mexico
- 8.4.3.1 Market Size and Forecast, By Technology
- 8.4.3.2 Market Size and Forecast, By Application
- 9 Europe Biotechnology Market Analysis and Forecast (2023-2030)
- 9.1 Introduction
- 9.2 Europe Biotechnology Market Share Analysis, By Technology
- 9.3 Europe Biotechnology Market Size and Forecast, By Application
- 9.4 Europe Biotechnology Market Size and Forecast, By Country
- 9.4.1 Germany
- 9.4.1.1 Market Size and Forecast, By Technology
- 9.4.1.2 Market Size and Forecast, By Application
- 9.4.2 France
- 9.4.2.1 Market Size and Forecast, By Technology
- 9.4.2.2 Market Size and Forecast, By Application
- 9.4.3 UK
- 9.4.3.1 Market Size and Forecast, By Technology
- 9.4.3.2 Market Size and Forecast, By Application
- 9.4.4 Russia
- 9.4.4.1 Market Size and Forecast, By Technology
- 9.4.4.2 Market Size and Forecast, By Application
- 9.4.5 Italy
- 9.4.5.1 Market Size and Forecast, By Technology
- 9.4.5.2 Market Size and Forecast, By Application
- 9.4.6 Spain
- 9.4.6.1 Market Size and Forecast, By Technology
- 9.4.6.2 Market Size and Forecast, By Application
- 9.4.7. Rest of Europe
- 9.4.7.1 Market Size and Forecast, By Technology
- 9.4.7.2 Market Size and Forecast, By Application
- 10 Asia Pacific Biotechnology Market Analysis and Forecast (2023-2030)
- 10.1 Introduction
- 10.2 Asia Pacific Biotechnology Market Share Analysis, By Technology
- 10.3 Asia Pacific Biotechnology Market Size and Forecast, By Application
- 10.4 Asia Pacific Biotechnology Market Size and Forecast, By Country
- 10.4.1 China
- 10.4.1.1 Market Size and Forecast, By Technology
- 10.4.1.2 Market Size and Forecast, By Application
- 10.4.2 Japan
- 10.4.2.1 Market Size and Forecast, By Technology
- 10.4.2.2 Market Size and Forecast, By Application
- 10.4.3 India
- 10.4.3.1 Market Size and Forecast, By Technology
- 10.4.3.2 Market Size and Forecast, By Application
- 10.4.4 South Korea
- 10.4.4.1 Market Size and Forecast, By Technology
- 10.4.4.2 Market Size and Forecast, By Application
- 10.4.5 Australia
- 10.4.5.1 Market Size and Forecast, By Technology
- 10.4.5.2 Market Size and Forecast, By Application
- 10.4.6 Newzealand
- 10.4.6.1 Market Size and Forecast, By Technology
- 10.4.6.2 Market Size and Forecast, By Application
- 10.4.7 Singapore
- 10.4.7.1 Market Size and Forecast, By Technology
- 10.4.7.2 Market Size and Forecast, By Application
- 10.4.8 Malaysia
- 10.4.8.1 Market Size and Forecast, By Technology
- 10.4.8.2 Market Size and Forecast, By Application
- 10.4.9. Rest of Asia Pacific
- 10.4.9.1 Market Size and Forecast, By Technology
- 10.4.9.2 Market Size and Forecast, By Application
- 11 Latin America Biotechnology Market Analysis and Forecast (2023-2030)
- 11.1 Introduction
- 11.2 Latin America Biotechnology Market Share Analysis, By Technology
- 11.3 Latin America Biotechnology Market Share Analysis, By Application
- 11.4 Latin America Biotechnology Market Size and Forecast, Country
- 11.4.1. Brazil
- 11.4.1.1 Market Size and Forecast, By Technology
- 11.4.1.2 Market Size and Forecast, By Application
- 11.4.2 Argentina
- 11.4.2.1 Market Size and Forecast, By Technology
- 11.4.2.2 Market Size and Forecast, By Application
- 11.4.3 Colombia
- 11.4.3.1 Market Size and Forecast, By Technology
- 11.4.3.2 Market Size and Forecast, By Application
- 11.4.4 Peru
- 11.4.4.1 Market Size and Forecast, By Technology
- 11.4.4.2 Market Size and Forecast, By Application
- 11.4.5 Chile
- 11.4.5.1 Market Size and Forecast, By Technology
- 11.4.5.2 Market Size and Forecast, By Application
- 11.4.6 Venezuela
- 11.4.6.1 Market Size and Forecast, By Technology
- 11.4.6.2 Market Size and Forecast, By Application
- 11.4.7. Rest of Latin America
- 11.4.7.1 Market Size and Forecast, By Technology
- 11.4.7.2 Market Size and Forecast, By Application
- 12 Middle East Biotechnology Market Analysis and Forecast (2023-2030)
- 12.1 Introduction
- 12.2 Middle East Biotechnology Market Share Analysis, By Technology
- 12.3 Middle East Biotechnology Market Size and Forecast, By Application
- 12.4 Middle East Biotechnology Market Size and Forecast, By Country
- 12.4.1. Saudi Arabia
- 12.4.1.1 Market Size and Forecast, By Technology
- 12.4.1.2 Market Size and Forecast, By Application
- 12.4.2. UAE
- 12.4.2.1 Market Size and Forecast, By Technology
- 12.4.2.2 Market Size and Forecast, By Application
- 12.4.3. Egypt
- 12.4.3.1 Market Size and Forecast, By Technology
- 12.4.3.2 Market Size and Forecast, By Application
- 12.4.4. Kuwait
- 12.4.4.1 Market Size and Forecast, By Technology
- 12.4.4.2 Market Size and Forecast, By Application
- 12.4.5. South Africa
- 12.4.5.1 Market Size and Forecast, By Technology
- 12.4.5.2 Market Size and Forecast, By Application
- 12.4.6 Venezuela
- 12.4.6.1 Market Size and Forecast, By Technology
- 12.4.6.2 Market Size and Forecast, By Application
- 13 Competitive Analysis
- 13.1 Competition Dashboard
- 13.2 Market share Analysis of Top Vendors
- 13.3 Key Development Strategies
- 14 Company Profiles
- 14.1 Gilead Sciences, Inc.
- 14.1.1 Overview
- 14.1.2 Offerings
- 14.1.3 Key Financials
- 14.1.4 Business Segment & Geographic Overview
- 14.1.5 Key Market Developments
- 14.1.6 Key Strategies
- 14.2. Bristol-Myers Squibb
- 14.2.1 Overview
- 14.2.2 Offerings
- 14.2.3 Key Financials
- 14.2.4 Business Segment & Geographic Overview
- 14.2.5 Key Market Developments
- 14.2.6 Key Strategies
- 14.3. Abbott Laboratories
- 14.3.1 Overview
- 14.3.2 Offerings
- 14.3.3 Key Financials
- 14.3.4 Business Segment & Geographic Overview
- 14.3.5 Key Market Developments
- 14.3.6 Key Strategies
- 14.4 Pfizer, Inc.
- 14.4.1 Overview
- 14.4.2 Offerings
- 14.4.3 Key Financials
- 14.4.4 Business Segment & Geographic Overview
- 14.4.5 Key Market Developments
- 14.4.6 Key Strategies
- 14.5 Amgen Inc.
- 14.5.1 Overview
- 14.5.2 Offerings
- 14.5.3 Key Financials
- 14.5.4 Business Segment & Geographic Overview
- 14.5.5 Key Market Developments
- 14.5.6 Key Strategies
- 14.6 Novo Nordisk A/S.
- 14.6.1 Overview
- 14.6.2 Offerings
- 14.6.3 Key Financials
- 14.6.4 Business Segment & Geographic Overview
- 14.6.5 Key Market Developments
- 14.6.6 Key Strategies
- 14.7 Merck KGaA
- 14.7.1 Overview
- 14.7.2 Offerings
- 14.7.3 Key Financials
- 14.7.4 Business Segment & Geographic Overview
- 14.7.5 Key Market Developments
- 14.7.6 Key Strategies
- 14.8 Johnson & Johnson Services, Inc.
- 14.8.1 Overview
- 14.8.2 Offerings
- 14.8.3 Key Financials
- 14.8.4 Business Segment & Geographic Overview
- 14.8.5 Key Market Developments
- 14.8.6 Key Strategies
- 14.9 Novartis AG
- 14.9.1 Overview
- 14.9.2 Offerings
- 14.9.3 Key Financials
- 14.9.4 Business Segment & Geographic Overview
- 14.9.5 Key Market Developments
- 14.9.6 Key Strategies
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.